Package 43598-537-05

{"route": ["ORAL"], "spl_id": "6364d3de-085f-44f8-d1e4-e6bfc5a854a7", "openfda": {"upc": ["0343598538600", "0343598536606"], "unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518", "993536"], "spl_set_id": ["6948f63b-599c-4956-a249-e9544beda9fc"], "manufacturer_name": ["Dr. Reddys Laboratories Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-537-01)", "package_ndc": "43598-537-01", "marketing_start_date": "20160801"}, {"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-537-05)", "package_ndc": "43598-537-05", "marketing_start_date": "20160801"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-537-60)", "package_ndc": "43598-537-60", "marketing_start_date": "20160801"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "43598-537_6364d3de-085f-44f8-d1e4-e6bfc5a854a7", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "43598-537", "generic_name": "bupropion hydrochloride", "labeler_name": "Dr. Reddys Laboratories Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA205794", "marketing_category": "ANDA", "marketing_start_date": "20160801", "listing_expiration_date": "20261231"}